'Post marketing' presentation slideshows

Assessing Risk in Drug Development

Assessing Risk in Drug Development. David M. Benjamin, Ph.D. Clinical Pharmacologist & Toxicologist Adjunct Assistant Professor - Tufts Medical School Fellow, American Academy of Forensic Sciences (Toxicology) Fellow, American Society for Healthcare Risk Management

555 views • 55 slides

Jon D. Duke, MD NLM Medical Informatics Fellow Regenstrief Institute Indiana University

Illuminating the Fine Print: Visualizing Medication Side-Effects in Complex Multi-drug Regimens. Jon D. Duke, MD NLM Medical Informatics Fellow Regenstrief Institute Indiana University. The QuARK Project. Quantitative Adverse R eaction Knowledgebase. The Tao of QuARK. The Concept

528 views • 52 slides

EXPERIMENTAL STUDIES

EXPERIMENTAL STUDIES. FRAMEWORK:. Introduction Types of experimental studies Randomized control trial Types of randomized controlled trial (RCT) Phases of clinical trial Design and conduct of an RCT General plan and protocol of an RCT Study population Randomization Blinding

791 views • 48 slides

461 views • 38 slides

Objectives/Agenda

Overview of the Role of the Regulatory Agencies and of Regulations in Product Development for Pharma Remit of EMA/FDA. Objectives/Agenda. The role of regulation History of regulation Control points Control of clinical trials NDA/MAA submission Comparison of pharma and device controls.

465 views • 36 slides

If You Build it, Will They Come?

If You Build it, Will They Come?. Krista Nelson 2011. Presentation Highlights. Topic: Marketing through New Media Goal of Presentation: Promote an understanding of how to market The Benefit Bank online service and grow TBB networks using email and social media

438 views • 33 slides

From bench to bedside : making the right question getting the right answers

From bench to bedside : making the right question getting the right answers Carlo Tomino Pharm.D . IRCCS San Raffaele, Rome. 2. CLINICAL Research: how we can get there?. 3. 4. We need (for the IMP): QUALITY data and PRE-CLINICAL data. 5. Than, we can move to the CLINICAL TRIAL.

332 views • 33 slides

482 views • 25 slides

The Safety of Tenofovir DF for the Treatment of HIV Infection: The First 4 Years

The Safety of Tenofovir DF for the Treatment of HIV Infection: The First 4 Years. M Nelson, 1 D Cooper, 2 R Schooley, 3 C Katlama, 4 J Montaner, 5 S Curtis, 6 L Hsu, 6 B Lu, 6 S Smith, 6 J Rooney, 6 and the Viread Global Expanded Access Program

291 views • 22 slides

Risk Assessments: Patient Safety and Innovation

213 views • 11 slides

Clinical Review Process for New Drug Development and Application

Clinical Review Process for New Drug Development and Application. Shen Xiao, MD, Ph.D. Senior Medical Officer Division of Cardiovascular and Renal Products Center for Drug Evaluation and Research (CDER) US FDA. Disclaimer.

126 views • 9 slides

Sara Young Digital Worth Academy Earn Money On Facebook With Amazon Affiliate Program

Comparing and score products is an excellent method for an Amazon niche evaluation blog site. Write quality content targeted to your main keyword. With the vast array of products, nobody can resist purchasing from Amazon.

21 views • 1 slides